Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Alvotech Holdings S.A.
Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
June 07, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
May 24, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®
May 16, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
May 11, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
April 19, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
April 06, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®
February 28, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech and Fuji Pharma Expand Partnership for Additional Biosimilar Candidate in Japan
February 23, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech Enters Exclusive Global Licensing Agreement with BiosanaPharma for Co-Development of a Proposed Biosimilar (AVT23) to Xolair® (Omalizumab)
February 02, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Million
January 18, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
December 07, 2021
From
Alvotech Holdings S.A.
Via
Business Wire
Tickers
OACB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.